Psychedelics for Mental Health: Help or Hype? скачать в хорошем качестве

Psychedelics for Mental Health: Help or Hype?

Magic mushrooms, MDMA, and Ketamine. These psychedelic drugs, once a taboo, might not be as harmful as we thought. Some scientific studies have shown evidence that psychedelic drugs, when used in controlled therapeutic settings, may help patients with anxiety, PTSD, and depression. While states like Oregon have legalized psilocybin therapy, the FDA recently decided in a high-profile case not to approve MDMA therapy. Should doctors still consider its use, or is it overhyped? Those who advocate for psychedelic treatments argue it could be a welcome relief for patients who don’t respond to traditional medications and therapies and help fill a critical gap in the therapeutic landscape. However, those against recommending psychedelics are concerned about its risks, including the possibility of worsening certain mental health conditions, and we don’t yet understand the long-term effects of psychedelic use. Now with this background, we debate the question: Psychedelics for Mental Health: Help or Hype? Arguing Help: Ismail Ali, Director of Policy and Advocacy at MAPS Arguing Hype: Kevin Sabet, President and CEO at the Foundation for Drug Policy Solutions Emmy award-winning journalist John Donvan moderates Timestamps: 00:00 Intro 02:56 Ismail Ali argues that psychedelics are help. 07:11 Kevin Sabet argues that psychedelics are hype. 11:45 Why should this topic be addressed? 14:44 Are there studies that confirm the effectiveness of MDMA in treating PTSD? 21:10 Is MAPS involved in dishonest science? 22:58 What criteria would a study need to meet to establish the efficacy of psychedelics as a treatment? 24:41 Could expanding access to psychedelics cause harm? 30:24 Is the use of psychedelics linked to instances of sexual misconduct? 33:36 Why does Kevin think that supporting the use of psychedelics as a treatment is cult-like? 35:43 Emily Witt asks whether emphasizing the therapeutic aspect of psychedelics is truly the best way to legitimize them. 40:16 Dr. Javier Muniz asks what it means for the FDA to consider psychedelics as a form of therapy. 46:14 Rachel Nuwer asks whether the media has influenced our perception of psychedelics. 53:11 Ismail and Kevin present their closing statements. #opentodebate #debate #PsychedelicsDebate #MentalHealthDebate #HelpOrHype #mushroom #fda #Psychedelics #MDMA #KetamineTherapy #Microdosing #PsychedelicTherapy #DrugPolicy #MAPS #KevinSabet #IsmailAli #AlternativeMedicine #psychedelicresearch =================================== Subscribe:    / @opentodebateorg   Official site: https://opentodebate.org/ Newsletter: https://opentodebate.org/insight/ X:   / opentodebateorg   Facebook:   / beopentodebate   LinkedIn:   / opentodebate   Instagram:   / opentodebateorg   TikTok:   / opentodebateorg   Open to Debate Apple Podcasts: https://tinyurl.com/bdzmz5xt Open to Debate Spotify Podcasts: https://tinyurl.com/22tuxu7h ===================================